Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7312052> ?p ?o }
Showing triples 1 to 36 of
36
with 100 triples per page.
- Q7312052 subject Q16819643.
- Q7312052 subject Q8492996.
- Q7312052 subject Q8965786.
- Q7312052 subject Q9092837.
- Q7312052 abstract "Remogliflozin etabonate (INN/USAN) is a proposed drug of the gliflozin class for the treatment of type 2 diabetes, investigated by GlaxoSmithKline. Remogliflozin is now being developed by BHV Pharma with Islet Sciences.".
- Q7312052 atcPrefix "none".
- Q7312052 casNumber "442201-24-3".
- Q7312052 fdaUniiCode "TR0QT6QSUL".
- Q7312052 iupacName "5-methyl-4-[4-(1-methylethoxy)benzyl]-1-(1-methylethyl)-1H-pyrazol-3-yl 6-O-(ethoxycarbonyl)-β-D-glucopyranoside".
- Q7312052 thumbnail Remogliflozin_etabonate_structure.svg?width=300.
- Q7312052 wikiPageWikiLink Q12206.
- Q7312052 wikiPageWikiLink Q15318183.
- Q7312052 wikiPageWikiLink Q16466508.
- Q7312052 wikiPageWikiLink Q16819643.
- Q7312052 wikiPageWikiLink Q20089925.
- Q7312052 wikiPageWikiLink Q212322.
- Q7312052 wikiPageWikiLink Q3041588.
- Q7312052 wikiPageWikiLink Q311213.
- Q7312052 wikiPageWikiLink Q4391435.
- Q7312052 wikiPageWikiLink Q4926095.
- Q7312052 wikiPageWikiLink Q824258.
- Q7312052 wikiPageWikiLink Q8492996.
- Q7312052 wikiPageWikiLink Q8965786.
- Q7312052 wikiPageWikiLink Q9092837.
- Q7312052 atcPrefix "none".
- Q7312052 casNumber "442201".
- Q7312052 iupacName "5".
- Q7312052 unii "TR0QT6QSUL".
- Q7312052 type ChemicalSubstance.
- Q7312052 type Drug.
- Q7312052 type ChemicalObject.
- Q7312052 type Thing.
- Q7312052 type Q8386.
- Q7312052 comment "Remogliflozin etabonate (INN/USAN) is a proposed drug of the gliflozin class for the treatment of type 2 diabetes, investigated by GlaxoSmithKline. Remogliflozin is now being developed by BHV Pharma with Islet Sciences.".
- Q7312052 label "Remogliflozin etabonate".
- Q7312052 depiction Remogliflozin_etabonate_structure.svg.